Methods of treatment of cancer by continuous infusion of coenzyme Q10
US9901542B2 · kind B2 · utility
9Cited by
115References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2014 |
| Grant date | Feb 27, 2018 |
| Priority date | — |
| Expiry date | Sep 4, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides regimens and methods for the treatment of cancer comprising continuous infusion of coenzyme Q10. The coenzyme Q10 may be administered as a monotherapy, or in combination with an additional agent, such as an anticancer agent, a chemotherapeutic agent, or an anti-angiogenic agent. The coenzyme Q10 may be administered at two or more different rates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.